BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11494141)

  • 1. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes.
    Suzuki C; Unoki M; Nakamura Y
    J Hum Genet; 2001; 46(3):155-7. PubMed ID: 11310585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN.
    Matsushima-Nishiu M; Unoki M; Ono K; Tsunoda T; Minaguchi T; Kuramoto H; Nishida M; Satoh T; Tanaka T; Nakamura Y
    Cancer Res; 2001 May; 61(9):3741-9. PubMed ID: 11325847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
    Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
    Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PTEN facilitates HIF-1-mediated gene expression.
    Zundel W; Schindler C; Haas-Kogan D; Koong A; Kaper F; Chen E; Gottschalk AR; Ryan HE; Johnson RS; Jefferson AB; Stokoe D; Giaccia AJ
    Genes Dev; 2000 Feb; 14(4):391-6. PubMed ID: 10691731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
    Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
    Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
    Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
    Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
    Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
    Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
    Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray.
    Hong TM; Yang PC; Peck K; Chen JJ; Yang SC; Chen YC; Wu CW
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):355-63. PubMed ID: 10970827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mammalian expression system for rapid production and purification of active MAP kinase phosphatases.
    Chen P; Hutter D; Liu P; Liu Y
    Protein Expr Purif; 2002 Apr; 24(3):481-8. PubMed ID: 11922765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models in tumor suppression.
    Ghebranious N; Donehower LA
    Oncogene; 1998 Dec; 17(25):3385-400. PubMed ID: 9917000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
    Turturro F; Frist AY; Arnold MD; Seth P; Pulford K
    Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.